1. Abb, J., 1985, Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III, Med. Microbiol. Immunol. 174: 205–210.
2. Abb, J., Abb, H., and Deinhardt, F., 1984, Age-related decline of human interferon alpha and interferon gamma production, Blut 48: 285–289.
3. Adams, E, Quesada, J. R., and Gutterman, J. U., 1984, Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer, J. Am. Med. Assoc. 252: 938–941.
4. Ahokas, A., Rimon, R., Koskiniemi, M., Vaheri, A., Julkunen, I., and Sarna, S., 1987, Viral antibodies and interferon in acute psychiatric disorders, J. Clin. Psychiatry 48: 194–196.
5. Albrecht, P., Boone, E., Torrey, E. F., Hicks, J. T., and Daniel, N., 1980b, Raised cytomegalovirus-